Evidence map›Paper›PMID 28428634›Full record

ReviewNature reviews. Gastroenterology & hepatology2017

Lipid droplets and liver disease: from basic biology to clinical implications.

Nina L Gluchowski, Michel Becuwe, Tobias C Walther, Robert V Farese

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 332 papers.

0numbers the graph read from it
0cells of the map it votes in
332citing papers in PubMed
22.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

332 citing papers in PubMed, 658 citations in OpenAlex.

  1. Trial
  2. Review
  3. Sequential Fractionation ofFoods (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

272 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nina L GluchowskiDepartment of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115, USA.
Michel BecuweDepartment of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115, USA.
Tobias C WaltherDepartment of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115, USA.
Robert V FareseDepartment of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, 655 Huntington Avenue, Boston, Massachusetts 02115, USA.
Harvard University · US

Funding

ROLE OF DGAT IN TRIACYLGLYCEROL METABOLISMR01DK056084 · NIDDK · J. DAVID GLADSTONE INSTITUTES · PI FARESE, ROBERT V · 2000 to 2014
$6.4M
Mechanisms of Lipid Droplet Protein TargetingR01GM097194 · NIGMS · YALE UNIVERSITY · PI WALTHER, TOBIAS C · 2011 to 2024
$4.9M
Physiology of Lipid Droplets and Triglyceride StorageR01DK101579 · NIDDK · HARVARD SCHOOL OF PUBLIC HEALTH · PI FARESE, ROBERT V · 2014 to 2018
$2.6M
The Mechanisms of Lipid Droplet Formation and RegulationR01GM099844 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI FARESE, ROBERT V · 2012 to 2015
$1.9M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK056084NIDDK NIH HHS R01 DK101579NIGMS NIH HHS R01 GM097194NIGMS NIH HHS R01 GM099844
6 · The paper itself

Abstract

Lipid droplets are dynamic organelles that store neutral lipids during times of energy excess and serve as an energy reservoir during deprivation. Many prevalent metabolic diseases, such as the metabolic syndrome or obesity, often result in abnormal lipid accumulation in lipid droplets in the liver, also called hepatic steatosis. Obesity-related steatosis, or NAFLD in particular, is a major public health concern worldwide and is frequently associated with insulin resistance and type 2 diabetes mellitus. Here, we review the latest insights into the biology of lipid droplets and their role in maintaining lipid homeostasis in the liver. We also offer a perspective of liver diseases that feature lipid accumulation in these lipid storage organelles, which include NAFLD and viral hepatitis. Although clinical applications of this knowledge are just beginning, we highlight new opportunities for identifying molecular targets for treating hepatic steatosis and steatohepatitis.

Indexed as

Hepatitis C, ChronicHumansLipid DropletsLipid MetabolismLiverLiver DiseasesMembrane LipidsNon-alcoholic Fatty Liver DiseaseMembrane Lipids

Identifiers

PMID28428634
PMCPMC6319657
OpenAlexW2605610684

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.